4.6 Article

Random Splicing of Several Exons Caused by a Single Base Change in the Target Exon of CRISPR/Cas9 Mediated Gene Knockout

期刊

CELLS
卷 5, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/cells5040045

关键词

RNA splicing; CRISPR; Cas9; genome editing; flotillin

资金

  1. state of Hessia (LOEWE Research Focus Non-neuronal Cholinergic Systems)

向作者/读者索取更多资源

The clustered regularly interspaced short palindromic repeats (CRISPR)-associated sequence 9 (CRISPR/Cas9) system is widely used for genome editing purposes as it facilitates an efficient knockout of a specific gene in, e.g. cultured cells. Targeted double-strand breaks are introduced to the target sequence of the guide RNAs, which activates the cellular DNA repair mechanism for non-homologous-end-joining, resulting in unprecise repair and introduction of small deletions or insertions. Due to this, sequence alterations in the coding region of the target gene frequently cause frame-shift mutations, facilitating degradation of the mRNA. We here show that such CRISPR/Cas9-mediated alterations in the target exon may also result in altered splicing of the respective pre-mRNA, most likely due to mutations of splice-regulatory sequences. Using the human FLOT-1 gene as an example, we demonstrate that such altered splicing products also give rise to aberrant protein products. These may potentially function as dominant-negative proteins and thus interfere with the interpretation of the data generated with these cell lines. Since most researchers only control the consequences of CRISPR knockout at genomic and protein level, our data should encourage to also check the alterations at the mRNA level.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Detailed profile of cognitive dysfunction in children with aspartylglucosaminuria

Elina Leena Harjunen, Minna Laine, Ritva Tikkanen, Paivi Helenius

JOURNAL OF INHERITED METABOLIC DISEASE (2020)

Article Clinical Neurology

Susceptibility-Weighted Imaging Findings in Aspartylglucosaminuria

A. Tokola, M. Laine, R. Tikkanen, T. Autti

AMERICAN JOURNAL OF NEURORADIOLOGY (2019)

Review Cell Biology

Succinic Semialdehyde Dehydrogenase Deficiency: An Update

Miroslava Didiasova, Antje Banning, Heiko Brennenstuhl, Sabine Jung-Klawitter, Claudio Cinquemani, Thomas Opladen, Ritva Tikkanen

Article Neurosciences

Statistical Permutation Test Reveals Progressive and Region-Specific Iron Accumulation in the Thalami of Children with Aspartylglucosaminuria

Viljami Sairanen, Anna Tokola, Ritva Tikkanen, Minna Laine, Taina Autti

BRAIN SCIENCES (2020)

Article Cell Biology

Knockout of the CMP-Sialic Acid Transporter SLC35A1 in Human Cell Lines Increases Transduction Efficiency of Adeno-Associated Virus 9: Implications for Gene Therapy Potency Assays

Antje Banning, Anna Zakrzewicz, Xin Chen, Steven J. Gray, Ritva Tikkanen

Summary: The study established human cell lines (HEK293T and HeLa) as permissive for AAV9 transduction by knocking out a CMP-sialic acid transporter, providing a model system for establishing potency assays for AAV9-based gene therapy for human diseases.
Article Dermatology

Human Desmocollin 3-Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus

Christoph Hudemann, Roberto Maglie, Maria Llamazares-Prada, Benedikt Beckert, Dario Didona, Ritva Tikkanen, Thomas Schmitt, Takashi Hashimoto, Jens Waschke, Michael Hertl, Ruediger Eming

Summary: This study suggests that anti-DSC3 IgG in a mouse model of pemphigus can cause acantholysis through the activation of p38 MAPKs and EGFR. Additionally, the induction of anti-human DSC3 IgG is associated with DSC3-specific T cells in association with HLA-DRB1*04:02.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Cell Biology

Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis

Antje Banning, Ritva Tikkanen

Summary: Splicing defects caused by mutations in consensus sequences are common in human diseases and often lead to loss of protein function. Modulation of splicing by small molecules may be an effective therapy for genetic diseases.
Article Cell Biology

Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene

Ada-Sophia Clees, Verena Stolp, Bjoern Haeupl, Dominik C. Fuhrmann, Frank Wempe, Marcel Seibert, Sarah Weber, Antje Banning, Ritva Tikkanen, Richard Williams, Bernhard Bruene, Hubert Serve, Frank Schnuetgen, Ivana von Metzler, Nina Kurrle

Summary: The study analyzed the adaptation of multiple myeloma cells to hypoxia, revealing changes in protein expression and regulation of specific proteins under hypoxic conditions, including the cysteine protease LGMN, which can impact the growth of multiple myeloma cells in hypoxic environments.
Article Cell Biology

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?

Anna Zakrzewicz, Celina Wuerth, Benedikt Beckert, Simon Feldhoff, Katrien Vanderheyden, Stian Foss, Jan Terje Andersen, Hans de Haard, Peter Verheesen, Vladimir Bobkov, Ritva Tikkanen

Summary: Blocking FcRn can stabilize keratinocyte monolayer and provide a novel treatment strategy for pemphigus.
Review Oncology

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

Valentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, Ilaria Plantamura, Elda Tagliabue, Serena Di Cosimo, Giulia Cosentino, Marilena V. Iorio

Summary: Breast cancer is the most commonly diagnosed malignancy in women globally, with 20% of cases being HER2 positive. Despite the improvement in prognosis with anti-HER2 agents, a significant number of patients do not respond to treatment. MicroRNAs are promising clinical tools for managing HER2 positive breast cancers due to their detectability and stability in tissues and blood, as well as their potential as therapeutic agents, prognostic and predictive biomarkers.

CANCERS (2022)

Article Neurosciences

Detection of Aspartylglucosaminuria Patients from Magnetic Resonance Images by a Machine-Learning-Based Approach

Arttu Ruohola, Eero Salli, Timo Roine, Anna Tokola, Minna Laine, Ritva Tikkanen, Sauli Savolainen, Taina Autti

Summary: Magnetic resonance imaging data can be used to develop computer-assisted diagnostic tools for neurodegenerative diseases. This study found that features extracted from different types of magnetic resonance images can effectively differentiate AGU patients from healthy controls.

BRAIN SCIENCES (2022)

Article Biochemistry & Molecular Biology

Validation of Aspartylglucosaminidase Activity Assay for Human Serum Samples: Establishment of a Biomarker for Diagnostics and Clinical Studies

Antje Banning, Minna Laine, Ritva Tikkanen

Summary: Novel treatment strategies for rare genetic diseases require reliable biomarkers to assess treatment effect. In this study, a validated fluorometric AGA activity assay was established for assessing AGA activity in human serum samples. The assay proved to be suitable for diagnosing AGU and potentially monitoring treatment effect.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Development of precision therapies for rare inborn errors of metabolism: Functional investigations in cell culture models

Miroslava Didiasova, Antje Banning, Ritva Tikkanen

Summary: Due to the low number of patients, rare genetic diseases pose a special challenge for therapy development. Precision medicine uses specific molecular information to elucidate effective therapy possibilities for patient-specific pathogenic variants. This review focuses on personalized precision medicine approaches for cost-effective and fast therapy development, including drug repurposing and suitable cell culture models.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Article Biochemistry & Molecular Biology

Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of ALDH5A1

Heiko Brennenstuhl, Miroslava Didiasova, Birgit Assmann, Mariarita Bertoldi, Gianluca Molla, Sabine Jung-Klawitter, Oya Kuseyri Huebschmann, Julian Schroter, Thomas Opladen, Ritva Tikkanen

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

暂无数据